Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project

Jul 17, 2017 by in CARDIOLOGY Comments Off on Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project

Summary Background A substantial number of patients with acute myocardial infarction (AMI) have polyvascular disease (PolyVD), defined as cerebrovascular disease (CVD), peripheral arterial disease (PAD) or both. Aim To investigate…

read more

Three-dimensional echocardiography of colour Doppler flow

Jul 17, 2017 by in CARDIOLOGY Comments Off on Three-dimensional echocardiography of colour Doppler flow

Summary Three-dimensional echocardiography of colour Doppler flow developed quickly with the advent of three-dimensional echocardiography. An increasing amount of research has shown that three-dimensional echocardiography of colour Doppler flow is…

read more

Valvular heart disease associated with benfluorex

Jul 17, 2017 by in CARDIOLOGY Comments Off on Valvular heart disease associated with benfluorex

A 57-year-old woman was referred for dyspnoea during mild exercise, especially during the past year. Electrocardiogram and chest X-ray demonstrated no significant anomaly. Nt-pro brain natriuretic peptide was moderately elevated…

read more

Tachycardia-induced cardiomyopathy in childhood

Jul 17, 2017 by in CARDIOLOGY Comments Off on Tachycardia-induced cardiomyopathy in childhood

A 14-year-old boy was referred to our institution for evaluation of heart failure potentially related to a tachycardia-induced cardiomyopathy. The condition was first diagnosed at the age of 7 years, because…

read more

An uncommon cause of dyspnoea

Jul 17, 2017 by in CARDIOLOGY Comments Off on An uncommon cause of dyspnoea

A 34-year-old woman presented to our hospital with a 9-month history of exertional dyspnoea and fatigue. She was a long-distance runner but over the preceding 9 months had developed progressive…

read more

Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

Jul 17, 2017 by in CARDIOLOGY Comments Off on Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

Summary Background Recent studies have demonstrated that blockade of the angiotensin II type 1 receptor with losartan decreases aortic damage in an animal model of Marfan syndrome (a KI mouse…

read more
Get Clinical Tree app for offline access